ScinoPharm Taiwan Ltd is a distinguished manufacturer of Active Pharmaceutical Ingredients (APIs) and a prominent contract development and manufacturing organisation (CDMO). Established in 1997, the company provides a comprehensive range of services to the global pharmaceutical industry, focusing on custom synthesis and API manufacturing. With cGMP production facilities, ScinoPharm is adept at supporting early-phase pharmaceutical activities and offers services tailored for both brand companies and the generic sector. The firm’s robust regulatory expertise, combined with cost-effective production capabilities available in Asia, positions it uniquely to address diverse global pharmaceutical R&D and manufacturing needs.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Contract Development and Manufacturing (CDMO)
– Custom synthesis of small molecules
– Development and manufacturing of intermediates
– Injectable product formulation
– API outsourcing for new drug development
– Peptide synthesis

ScinoPharm Taiwan Ltd is committed to the advancement of high-quality and innovative APIs, employing a “Double-A” strategy to enhance its influence in the global market. For further information, please visit scinopharm.com.